Healthcare+

Carpmaels & Ransford promotes four Senior Associates as of 1st July 2023
Senior Associate promotions further the Healthcare credentials of the firm
Read More
06
Jul
2023
G 1/23: New referral concerning the novelty of commercially available products
What is the role of enablement in this assessment?
Read More
29
Jun
2023
Carpmaels attends Enlarged Board of Appeal hearing on priority entitlement
The EPO Enlarged Board of Appeal held its oral proceedings on Friday 26th May 2023, to consider the law on formal priority entitlement. Carpmaels & Ransford attended the hearing on behalf of Novartis
Read More
30
May
2023
Who’s Who Legal 2023: Life Sciences 2023
Carpmaels & Ransford partners recognised as leading patent litigation lawyers in life sciences
Read More
04
May
2023
The European Commission publishes its reforms to the EU’s rules for medicines
If accepted into legislation, the proposed reforms will change regulatory data protection and exclusivity periods available for innovative medicines
Read More
27
Apr
2023
The Windsor Framework: Potential Implications for UK SPCs
If accepted into law, the framework will bring changes to the way in which medicines in Northern Ireland are regulated, which could affect SPCs in the UK
Read More
18
Apr
2023
When can you use newly filed data to support inventive step at the EPO?
The EPO’s highest court has issued its long-awaited decision in G2/21 regarding the use of post-published evidence to support inventive step
Read More
24
Mar
2023
Carpmaels in Conversation: Ep. 21 – Changes to Clinical Trials – the Patent Perspective
Podcast
Read More
02
Mar
2023
The New EU Clinical Trials Regulation: Implications for patent filings
The EU is changing both the amount of clinical trial information that may be made available to the public and the timing for publication
Read More
27
Jan
2023
LMG Life Sciences Awards EMEA 2022
Carpmaels & Ransford nominated in five categories
Read More
31
Mar
2022

Type

Service

Sector

Archive